{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:00:56Z","timestamp":1788908456491,"version":"build-2803163510"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8932-17","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:12:28Z","timestamp":1507673548000},"page":"3199-3204","source":"Crossref","is-referenced-by-count":15,"title":["Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma"],"prefix":"10.2169","volume":"56","author":[{"given":"Takaaki","family":"Murakami","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Masui","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisho","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Service FJ, McMahon MM, O&apos;Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719, 1991."},{"key":"2","unstructured":"2. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58-64, 2015."},{"key":"3","unstructured":"3. Whipple AO, Frantz VK. Adenoma of islet cells with hypeinsulinism: a review. Ann Surg 101: 1299-1335, 1935."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Imamura M. Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 16: 4519-4525, 2010.","DOI":"10.3748\/wjg.v16.i36.4519"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ding Y, Wang S, Liu J, et al. Neuropsychiatric profiles of patients with insulinomas. Eur Neurol 63: 48-51, 2010.","DOI":"10.1159\/000268166"},{"key":"6","unstructured":"6. Graves TD, Gandhi S, Smith SJ, Sisodiya SM, Conway GS. Misdiagnosis of seizures: insulinoma presenting as adult-onset seizure disorder. J Neurol Neurosurg Psychiatry 75: 1091-1092, 2004."},{"key":"7","unstructured":"7. Aupy J, Benoilid A, Sarhan M, Dalvit C, Valenti MP, Hirsch E. Misleading features of neuroimaging and electroencephalography: insulinoma misdiagnosed as temporal lobe epilepsy. Epileptic Disord 15: 93-97, 2013."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dion MH, Cossette P, St-Hilaire JM, Rasio E, Nguyen DK. Insulinoma misdiagnosed as intractable epilepsy. Neurology 62: 1443-1445, 2004.","DOI":"10.1212\/01.WNL.0000120751.67940.3A"},{"key":"9","unstructured":"9. Deleo F, Matricardi S, Didato G, et al. An unusual behavioural and motor paroxysmal disorder caused by insulinoma-related hypoglycemia: a possible cause of epilepsy misdiagnosis. Seizure 23: 909-911, 2014."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Insulinoma with early-morning abnormal behavior. Intern Med 46: 405-408, 2007.","DOI":"10.2169\/internalmedicine.46.6071"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Park SH, Kim DW. Insulinoma presenting as medically intractable temporal lobe epilepsy. J Epilepsy Res 4: 21-23, 2014.","DOI":"10.14581\/jer.14005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260: E67-E74, 1991.","DOI":"10.1152\/ajpendo.1991.260.1.E67"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol 68: 912-918, 2008.","DOI":"10.1111\/j.1365-2265.2007.03161.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tesfaye N, Seaquist ER. Neuroendocrine response to hypoglycemia. Ann N Y Acad Sci 1212: 12-28, 2010.","DOI":"10.1111\/j.1749-6632.2010.05820.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakamoto Y, Ishimori T, Sano K, et al. Clinical efficacy of dual-phase scanning using <sup>68<\/sup>Ga-DOTATOC-PET\/CT in the detection of neuroendocrine tumours. Clin Radiol 71: 1069.e1-1069.e5, 2016.","DOI":"10.1016\/j.crad.2016.04.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med 106: 307-310, 1999.","DOI":"10.1016\/S0002-9343(99)00021-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imamura M, Nakamoto Y, Uose S, Komoto I, Awane M, Taki Y. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors. J Hepatobiliary Pancreat Sci 22: 602-609, 2015.","DOI":"10.1002\/jhbp.209"},{"key":"18","unstructured":"18. Stefanini P, Carboni M, Patrassi N, Basoli A. Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 75: 597-609, 1974."},{"key":"19","unstructured":"19. Del Campo M, Abdelmalik PA, Wu CP, Carlen PL, Zhang L. Seizure-like activity in the hypoglycemic rat: lack of correlation with the electroencephalogram of free-moving animals. Epilepsy Res 83: 243-248, 2009."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mitrakou A, Fanelli C, Veneman T, et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 329: 834-839, 1993.","DOI":"10.1056\/NEJM199309163291203"},{"key":"21","unstructured":"21. Rokutan M, Yabe D, Komoto I, et al. A case of insulinoma with non-alcoholic fatty liver disease: roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease. Endocr J 62: 1025-1030, 2015."},{"key":"22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","volume":"62","author":"JA French","year":"2004","unstructured":"22. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62: 1261-1273, 2004.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 94: 1069-1073, 2009.","DOI":"10.1210\/jc.2008-2031"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/23\/56_8932-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:40:02Z","timestamp":1570192802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/23\/56_8932-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":23,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8932-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}